Ozempic and hair loss: what's actually going on

Semaglutide (sold as Ozempic and Wegovy) and tirzepatide (sold as Mounjaro) have changed weight management for a huge number of people. They've also, for a noticeable subset of those people, coincided with real hair shedding — enough that "Ozempic hair loss" is now a widely searched term in its own right. We get asked about it often enough that it deserves a straight, sourced answer rather than either dismissal or scaremongering.

Before anything else: we fit non-surgical hair systems, not medication. We're not qualified to advise on GLP-1 prescriptions, and nothing here should be read as medical advice. If you're on one of these medications and noticing shedding, the right first conversation is with the doctor who prescribed it.

Is there really a connection?

Yes — as an observed association, not yet as settled, proven cause-and-effect. A 2025 letter in the journal Skin Health and Disease reviewed the evidence so far: a retrospective cohort study (Burke et al.) found a notable association between GLP-1 receptor agonists and increased alopecia; a scoping review (Tran et al.) documented frequent reports of hair loss among semaglutide's dermatological effects; and a disproportionality analysis of the FDA's own Adverse Event Reporting System (Godfrey et al.) found a consistent signal for both semaglutide and tirzepatide. The letter is explicit that causality "cannot be definitively established" from this kind of data, and calls for proper prospective trials — but notes the consistency across several independent sources "enhances the biological plausibility" of a real connection.

What's likely actually happening

The same 2025 letter sets out the leading explanation: rapid, substantial weight loss — exactly what these medications are designed to produce — can bring on shortfalls in iron, zinc, vitamin D and biotin, nutrients the hair growth cycle depends on. A shortfall like that is a well-recognised trigger for telogen effluvium, the same diffuse, temporary shedding condition that can follow stress, illness or any other significant disruption to the body. The NHS's own list of causes for this kind of hair loss names weight loss directly, alongside illness, stress and iron deficiency — so the pattern fits what's already well understood about shedding, rather than describing something entirely new. The letter also raises a second possible route: subtle thyroid hormone fluctuations linked to GLP-1 use, since thyroid hormones play a real role in keeping the hair cycle on track.

Put simply: the leading theory isn't that the medication attacks hair directly, but that losing weight quickly can starve the hair cycle of what it needs to keep running normally — the same mechanism behind shedding after a crash diet, a major illness or bariatric surgery, just newly visible because so many more people are now losing weight this quickly, this often.

How this differs from pattern baldness

Pattern hair loss is hereditary and hormone-driven, follows a predictable shape (the stages set out on the Norwood scale), and doesn't reverse on its own. Weight-loss-related shedding looks different: it's diffuse, spread fairly evenly across the whole scalp rather than concentrated at the hairline or crown, and for most people it's temporary rather than progressive. The two aren't mutually exclusive — someone with underlying pattern loss can have it become more visible once a separate, temporary shed thins things out on top — which is one more reason a proper look beats guessing.

Should you stop the medication?

That's not a question this article, or a hair studio, can answer — it's a conversation for whoever prescribed it. They can weigh the shedding against the reason you're taking it, check for a genuine nutritional deficiency with a simple blood test rather than guessing at supplements, and decide whether any change makes sense. Making that call alone, based on an internet article, isn't a good idea either way.

What usually happens next

There's no GLP-1-specific trial data yet on exactly how long this takes to resolve, but it fits the general telogen effluvium pattern: the ISHRS puts full self-resolution at around 95% of cases within 2 to 3 months once the trigger eases, with regaining previous density taking longer again — up to 18 months or more, since new hair only grows a quarter to half an inch a month. Because the trigger here (continued weight loss, or an ongoing deficiency) can still be active rather than a one-off event, it's sensible to expect this to run on the longer side of that range, and worth getting it checked rather than assuming it will simply sort itself out.

Where does a hair system fit in?

Usually nowhere in the short term — if this is straightforward, temporary shedding, the most useful thing is to get the underlying cause checked and address it (often simply correcting a confirmed deficiency), then let the hair cycle reset. A hair system isn't a treatment for a condition that's likely to resolve on its own. Where it does become relevant is if the shedding turns out to be genuinely long-running, or if an assessment uncovers underlying pattern loss developing alongside it. In that case, a hair system gives you a full, natural-looking result immediately, at any stage, rather than asking you to wait out a biological process that may or may not fully resolve.

If that's where you've landed — after getting it properly checked, not instead of — a free consultation is a no-pressure way to see what a system would actually involve, including what it costs.

References

• Haykal, D. — "Alopecia and Semaglutide: Connecting the Dots for Patient Safety", Skin Health and Disease (2025) · pmc.ncbi.nlm.nih.gov/articles/PMC11909624/
• NHS — Hair loss · nhs.uk/conditions/hair-loss/
• International Society of Hair Restoration Surgery — Telogen Effluvium · ishrs.org/telogen-effluvium/